| Literature DB >> 29125568 |
Marietta Białoń1, Teresa Krzyśko-Łupicka2, Agnieszka Pik3, Piotr P Wieczorek4.
Abstract
This study addresses the chemical composition of some commercial essential oils (clove, juniper, oregano, and marjoram oils), as well as appropriate herbal extracts obtained in the process of cold maceration and their biological activity against selected Escherichia coli strains: E. coli ATTC 25922, E. coli ATTC 10536, and E. coli 127 isolated from poultry waste. On the basis of the gas chromatography-mass spectrometry (GCMS) analysis, it was found that the commercial essential oils revealed considerable differences in terms of the composition and diversity of terpenes, terpenoids and sesquiterpenes as compared with the extracts obtained from plant material. The commercial clove, oregano, and marjoram oils showed antibacterial properties against all the tested strains of E. coli. However, these strains were not sensitive to essential oils obtained from the plant material in the process of maceration. The tested strains of E. coli show a high sensitivity, mainly against monoterpenes (α-pinene, β-pinene, α,β,γ-terpinene, limonene) and some terpenoids (thymol, carvacrol). The commercial juniper oil contained mainly monoterpenes and monoterpenoids, while the extracts contained lower amounts of monoterpenes and high amounts of sesquiterpenes-the anti-microbiotic properties of the juniper herbal extract seem to be caused by the synergistic activity of mono- and sesquiterpenes.Entities:
Keywords: Escherichia coli; essential oils; gas chromatography-mass spectrometry
Mesh:
Substances:
Year: 2017 PMID: 29125568 PMCID: PMC6150398 DOI: 10.3390/molecules22111887
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
The extraction efficacy of the tested plant raw material.
| Oil | Extraction Efficacy (%) | |
|---|---|---|
| Cold Extraction—Maceration | Hot Extraction—Soxhlet Apparatus | |
| Clove | 20.3 | 20.6 |
| Juniper | 13.1 | 12.4 |
| Oregano | 4.0 | 3.3 |
| Marjoram | 12.2 | 12.6 |
Comparison of the composition of particular compounds in clove oils.
| Compound | Area (%) ± Standard Deviation (SD) | ||
|---|---|---|---|
| Commercial | Maceration | Soxhlet Apparatus | |
| 0.07 ± 0.01 | - | - | |
| 0.08 ± 0.00 | - | - | |
| 0.02 ± 0.01 | - | - | |
| 0.66 ± 0.02 | - | - | |
| 0.36 ± 0.04 | - | - | |
| Terpinolene | 0.03 ± 0.01 | - | - |
| 0.27 ± 0.01 | - | - | |
| Camphene | 0.05 ± 0.01 | - | - |
| 0.05 ± 0.01 | - | - | |
| Sum | 1.56 | - | - |
| Menthol | 0.02 ± 0.01 | - | - |
| Eugenol | 61.94 ± 0.23 | 54.16 ± 0.61 | 54.69 ± 0.21 |
| Eugenyl acetate | 4.13 ± 0.13 | 23.49 ± 0.61 | 27.65 ± 0.12 |
| 1,8-cineole | 12.07 ± 0.46 | - | 0.05 ± 0.007 |
| Bornyl acetate | 0.08 ± 0.02 | - | - |
| Sum | 78.24 | 77.65 | 82.39 |
| - | 0.16 ± 0.01 | - | |
| 3.03 ± 0.03 | 1.85 ± 0.04 | 1.41 ± 0.02 | |
| - | 0.23 ± 0.02 | 0.14 ± 0.01 | |
| 0.10 ± 0.01 | 0.71 ± 0.04 | 0.56 ± 0.03 | |
| - | 0.34 ± 0.02 | 0.24 ± 0.02 | |
| 15.86 ± 0.19 | 15.76 ± 0.38 | 13.11 ± 0.33 | |
| - | 2.00 ± 0.31 | 1.24 ± 0.22 | |
| - | - | ||
| - | 0.08 ± 0.01 | - | |
| Sum | 18.99 | 21.13 | 16.70 |
| Cubebol | - | 0.13 ± 0.02 | - |
| Caryophyllene oxide | 0.87 ± 0.02 | 0.40 ± 0.03 | 0.45 ± 0.04 |
| Sum | 0.87 | 0.53 | 0.45 |
| Methyl salicylate | 0.14 ± 0.03 | - | 0.03 ± 0.01 |
| 2,3,4-Trimethoxyacetophenone | - | 0.49 ± 0.15 | 0.18 ± 0.01 |
| Chavikol | 0.17 ± 0.01 | 0.18 ± 0.04 | 0.21 ± 0.03 |
| Sum | 0.31 | 0.67 | 0.42 |
Figure 1The composition of the main components in the clove commercial oil and extracts obtained in the process of cold and hot extraction.
Comparison of the composition of particular compounds in juniper oils.
| Compound | Area (%) ± SD | ||
|---|---|---|---|
| Commercial | Maceration | Soxhlet Apparatus | |
| 12.71 ± 0.23 | - | - | |
| 0.48 ± 0.06 | - | - | |
| 2.46 ± 0.18 | - | - | |
| 3.15 ± 0.25 | - | - | |
| Terpinolene | 15.39 ± 0.12 | - | - |
| - | 0.18 ± 0.01 | - | |
| Limonene | - | 3.98 ± 0.12 | 2.75 ± 0.01 |
| 21.79 ± 0.49 | 27.18 ± 0.82 | 26.51 ± 0.09 | |
| Camphene | 4.49 ± 0.18 | - | - |
| 4.35 ± 0.19 | 2.49 ± 0.10 | 2.32 ± 0.12 | |
| 1.42 ± 0.09 | |||
| 2.00 ± 0.14 | 11.01 ± 0.30 | 7.37 ± 0.05 | |
| 4-Carene | 0.28 ± 0.02 | - | - |
| 3-Carene | 14.23 ± 0.19 | - | - |
| 2-Carene | 2.41 ± 0.18 | - | - |
| Sabinene | 2.78 ± 0.19 | 3.59 ± 0.13 | 2.61 ± 0.07 |
| Sum | 87.94 | 48.43 | 41.56 |
| Terpinen-4-ol | 2.34 ± 0.07 | 0.49 ± 0.01 | 0.54 ± 0.01 |
| 0.45 ± 0.03 | - | - | |
| Thymol methyl ether | 0.28 ± 0.08 | - | - |
| 0.52 ± 0.02 | - | - | |
| Bornyl acetete | 4.04 ± 0.04 | 0.33 ± 0.02 | 0.38 ± 0.01 |
| Borneol | 0.28 ± 0.03 | - | - |
| Thujone | 0.11 ± 0.02 | - | - |
| Fenchyl acetate | 0.13 ± 0.02 | - | - |
| Sum | 8.15 | 0.82 | 0.92 |
| 0.63 ± 0.03 | 4.13 ± 0.14 | 4.76 ± 0.05 | |
| 0.08 ± 0.01 | - | - | |
| - | 0.65 ± 0.03 | 0.80 ± 0.06 | |
| Elixene | 0.06 ± 0.02 | - | - |
| Germacrene D | 0.09 ± 0.01 | 3.57 ± 0.54 | 3.85 ± 0.13 |
| - | 1.43 ± 0.04 | 1.54 ± 0.05 | |
| 1.06 ± 0.01 | 5.06 ± 0.17 | 5.24 ± 0.02 | |
| 0.05 ± 0.01 | 1.00 ± 0.05 | 1.23 ± 0.01 | |
| 0.10 ± 0.01 | 0.61 ± 0.06 | 0.59 ± 0.01 | |
| 0.09 ± 0.01 | 0.45 ± 0.05 | 0.49 ± 0.01 | |
| Alloaromadendrene | - | 0.46 ± 0.02 | 0.44 ± 0.01 |
| 0.16 ± 0.01 | - | - | |
| 0.57 ± 0.01 | 1.38 ± 0.03 | 1.80 ± 0.03 | |
| 0.08 ± 0.01 | - | - | |
| Epizonarene | - | 0.61 ± 0.01 | 0.96 ± 0.05 |
| - | 0.64 ± 0.04 | - | |
| - | - | 0.73 ± 0.03 | |
| Longifolene | 0.17 ± 0.01 | - | - |
| Sum | 3.14 | 19.99 | 22.43 |
| Cubebol | - | 1.83 ± 0.16 | 1.83 ± 0.05 |
| Caryophyllene oxide | 0.19 ± 0.02 | 3.82 ± 0.87 | 4.57 ± 0.08 |
| Spathulenol | - | - | 1.40 ± 0.10 |
| 0.06 ± 0.01 | - | - | |
| Sum | 0.25 | 5.65 | 7.80 |
| Estragole | 0.16 ± 0.02 | - | - |
| Cuparene | 0.36 ± 0.01 | - | - |
| Unseparated | - | 25.11 ± 0.28 | 27.29 ± 0.21 |
| Sum | 0.52 | 25.11 | 27.29 |
Figure 2The composition of the main components in the juniper commercial oil and extracts obtained in the process of cold and hot extraction.
Comparison of the composition of particular compounds in oregano oils.
| Compound | Area (%) ± SD | ||
|---|---|---|---|
| Commercial | Maceration | Soxhlet Apparatus | |
| - | 4.01 ± 0.25 | 4.03 ± 0.08 | |
| - | 0.94 ± 0.11 | 1.14 ± 0.07 | |
| - | 13.69 ± 0.52 | 13.08 ± 0.39 | |
| 0.13 ± 0.01 | - | - | |
| 23.74 ± 0.30 | 5.98 ± 0.28 | 5.45 ± 0.11 | |
| 0.67 ± 0.02 | 2.04 ± 0.22 | 2.49 ± 0.12 | |
| Terpinolene | 1.62 ± 0.05 | - | - |
| Limonene | 15.47 ± 0.62 | - | - |
| 5.90 ± 0.04 | - | - | |
| Camphene | 0.80 ± 0.04 | - | - |
| 0.09 ± 0.01 | - | - | |
| 2-Carene | 1.70 ± 0.08 | - | - |
| Bornylene | 1.05 ± 0.04 | - | - |
| Sum | 51.17 | 26.66 | 26.19 |
| Linalool | 1.57 ± 0.01 | - | - |
| Terpinen-4-ol | 0.09 ± 0.01 | - | - |
| 2.28 ± 0.07 | - | - | |
| 0.36 ± 0.02 | 1.34 ± 0.06 | 1.49 ± 0.08 | |
| Thymol | 11.17 ± 0.54 | 2.53 ± 0.15 | 2.13 ± 0.09 |
| 32.69 ± 0.43 | - | 1.52 ± 0.04 | |
| Thymol methyl ether | - | 0.63 ± 0.05 | 0.52 ± 0.02 |
| Carvacrol | - | 1.80 ± 0.42 | - |
| Isothymol methyl ether | - | - | 0.69 ± 0.01 |
| 1,8-cineole | - | - | 1.41 ± 0.08 |
| 0.51 ± 0.02 | - | - | |
| - | 3.07 ± 0.17 | 2.74 ± 0.08 | |
| Sum | 48.67 | 9.37 | 10.50 |
| - | 1.23 ± 0.07 | 1.05 ± 0.05 | |
| - | 1.69 ± 0.06 | - | |
| - | 8.81 ± 0.24 | 7.55 ± 0.01 | |
| 0.16 ± 0.01 | 10.51 ± 0.16 | 8.49 ± 0.21 | |
| - | 0.85 ± 0.03 | - | |
| - | 1.36 ± 0.07 | 1.20 ± 0.06 | |
| - | 3.36 ± 0.10 | 3.14 ± 0.12 | |
| Alloaromadendrene | - | 1.66 ± 0.06 | 1.45 ± 0.10 |
| - | 1.09 ± 0.07 | 0.97 ± 0.03 | |
| - | - | 0.81 ± 0.09 | |
| Sum | 0.16 | 30.56 | 24.66 |
| Caryophyllene oxide | - | 19.41 ± 0.15 | 16.15 ± 0.06 |
| Sum | - | 19.41 | 16.15 |
| Triacontyl acetate | - | 14.51 ± 0.52 | 16.61 ± 0.25 |
| Linolenic acid | - | - | 5.89 ± 0.25 |
| Sum | - | 14.51 | 22.50 |
Figure 3The composition of the main components in the oregano commercial oil and extracts obtained in the process of cold and hot extraction.
Comparison of the composition of particular compounds in marjoram oils.
| Compound | Area (%) ± SD | ||
|---|---|---|---|
| Commercial | Maceration | Soxhlet Apparatus | |
| - | 1.26 ± 0.11 | - | |
| 0.23 ± 0.01 | - | - | |
| 4.49 ± 0.09 | 1.16 ± 0.20 | - | |
| Terpinolene | 1.10 ± 0.01 | - | - |
| 2.40 ± 0.09 | 0.42 ± 0.04 | - | |
| Limonene | 23.47 ± 0.18 | - | - |
| 0.71 ± 0.01 | - | - | |
| 0.66 ± 0.01 | - | - | |
| 2.07 ± 0.08 | - | - | |
| 2-Carene | 2.67 ± 0.05 | - | - |
| Tricyclene | - | 24.36 ± 0.15 | 26.37 ± 0.23 |
| Sum | 37.80 | 27.20 | 26.37 |
| Linalool | 17.25 ± 0.08 | - | - |
| Eugenol | 1.55 ± 0.03 | - | - |
| 0.51 ± 0.03 | 1.06 ± 0.04 | 0.69 ± 0.01 | |
| Terpinen-4-ol | 8.93 ± 0.11 | 7.06 ± 0.09 | 6.94 ± 0.09 |
| 9.09 ± 0.11 | 4.89 ± 0.04 | 5.63 ± 0.11 | |
| Stereoisomers of | - | 6.08 ± 0.09 | 4.91 ± 0.04 |
| 1.11 ± 0.07 | 35.70 ± 0.17 | 35.01 ± 0.06 | |
| - | 0.56 ± 0.01 | 0.44 ± 0.01 | |
| Camphor | 0.33 ± 0.01 | - | - |
| Bornyl acetate | 0.20 ± 0.01 | - | - |
| Sum | 38.97 | 55.35 | 53.62 |
| Elixene | 0.16 ± 0.01 | - | - |
| 0.64 ± 0.02 | 3.89 ± 0.11 | 3.99 ± 0.05 | |
| Bicyclogermacrene | - | 0.89 ± 0.03 | 0.63 ± 0.02 |
| Sum | 0.80 | 4.78 | 4.62 |
| Spathulenol | - | 2.19 ± 0.08 | 2.64 ± 0.08 |
| Sum | - | 2.19 | 2.64 |
| - | 3.31 ± 0.12 | 4.60 ± 0.08 | |
| Sum | - | 3.31 | 4.60 |
| Linalyl anthranilate | 16.63 ± 0.05 | - | - |
| Estragole | 5.77 ± 0.04 | - | - |
| Eicosane | - | 7.29 ± 0.15 | 8.15 ± 0.10 |
| Sum | 22.40 | 7.29 | 8.15 |
Figure 4The composition of the main components in the marjoram commercial oil and extracts obtained in the process of cold and hot extraction.
The zones of inhibition of E. coli strains in the presence of essential oils.
| Oil Concentration (%) | Zones of Inhibition (mm) ± SD | |||||
|---|---|---|---|---|---|---|
| Commercial | Maceration | Commercial | Maceration | Commercial | Maceration | |
| 0.25 | 0 | 0 | 0 | 0 | 0 | 0 |
| 0.5 | 12.5 ± 0.7 | 0 | 9.5 ± 0.7 | 0 | 0 | 0 |
| 1.0 | 12.5 ± 0.7 | 0 | 11.0 ± 0.0 | 0 | 0 | 0 |
| 1.5 | 14.0 ± 1.4 | 0 | 12.0 ± 1.4 | 0 | 9.5 ± 0.7 | 0 |
| 2.0 | 15.0 ± 0.0 | 0 | 13.5 ± 0.7 | 0 | 11.0 ± 0.0 | 0 |
| 0.25 | 0 | 15.0 ± 0.0 | 0 | 0 | 0 | 0 |
| 0.5 | 0 | 17.5 ± 0.7 | 0 | 0 | 0 | 0 |
| 1.0 | 0 | 16.5 ± 0.7 | 0 | 0 | 0 | 0 |
| 1.5 | 0 | 14.5 ± 0.7 | 0 | 0 | 0 | 0 |
| 2.0 | 0 | 13.5 ± 0.7 | 0 | 0 | 0 | 0 |
| 0.25 | 0 | 0 | 12.5 ± 0.7 | 0 | 0 | 0 |
| 0.5 | 14.0 ± 1.4 | 0 | 20.0 ± 0.0 | 0 | 17.5 ± 0.7 | 0 |
| 1.0 | 13.5 ± 0.7 | 0 | 19.0 ± 1.4 | 0 | 16.0 ± 0.0 | 0 |
| 1.5 | 13.0 ± 0.0 | 0 | 16.5 ± 2.1 | 0 | 17.0 ± 1.4 | 0 |
| 2.0 | 14.0 ± 0.0 | 0 | 14.5 ± 0.7 | 0 | 18.0 ± 0.0 | 0 |
| 0.25 | 0 | 0 | 0 | 0 | 7.5 ± 10.6 | 0 |
| 0.5 | 0 | 0 | 0 | 0 | 12.0 ± 0.0 | 0 |
| 1.0 | 6.5 ± 9.2 | 0 | 0 | 0 | 12.5 ± 0.7 | 0 |
| 1.5 | 13.0 ± 0.0 | 0 | 13.0 ± 1.4 | 0 | 12.0 ± 0.0 | 0 |
| 2.0 | 13.5 ± 0.7 | 0 | 12.5 ± 0.7 | 0 | 13.0 ± 0.0 | 0 |
Figure 5Zones of inhibition of the tested E. coli strains against the clove oils. 1: commercial oil; 2: cold extract.
Figure 6Zones of inhibition of the tested E. coli strains against the juniper oils. 1: commercial oil; 2: cold extract.
Figure 7Zones of inhibition of the tested E. coli strains against the oregano oils. 1: commercial oil; 2: cold extract.
Figure 8Zones of inhibition of the tested E. coli strains against the marjoram oils. 1: commercial oil; 2: cold extract.